Cue Biopharma Inc.

NASDAQ: CUE · Real-Time Price · USD
0.81
0.02 (2.53%)
At close: Aug 15, 2025, 3:59 PM
0.83
2.48%
After-hours: Aug 15, 2025, 04:46 PM EDT

Cue Biopharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-40.67M -50.73M -53.01M -44.16M
Depreciation & Amortization
2.35M 3.44M 1.81M -1.78M
Stock-Based Compensation
6.85M 8.18M 9.5M 11.52M
Other Working Capital
-5M -63K -2.81M -7.97M
Other Non-Cash Items
74K 90K -453.9K -26.13K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-4.92M -934K 356.27K -4.39M
Operating Cash Flow
-36.33M -39.96M -41.81M -38.84M
Capital Expenditures
-66K n/a -170.75K -913.04K
Cash Acquisitions
n/a n/a 6.21K 4.58K
Purchase of Investments
n/a n/a -29.45M -4.58K
Sales Maturities Of Investments
n/a 25M 5M 10M
Other Investing Acitivies
98K 2K n/a 21.55K
Investing Cash Flow
32K 25M -24.61M 9.11M
Debt Repayment
-4M -2M 10M n/a
Common Stock Repurchased
n/a n/a n/a -750.13K
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
18K 473K 4.36M 1.85M
Financial Cash Flow
10.24M 11.86M 53.66M 19.23M
Net Cash Flow
-26.05M -3.1M -12.76M -10.5M
Free Cash Flow
-36.4M -39.96M -41.98M -39.75M